ZENTIVA S.A. (SCD) - Total Assets
Based on the latest financial reports, ZENTIVA S.A. (SCD) holds total assets worth RON1.85 Billion RON (≈ $424.20 Million USD) as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ZENTIVA S.A. - Total Assets Trend (2019–2024)
This chart illustrates how ZENTIVA S.A.'s total assets have evolved over time, based on quarterly financial data. Also see ZENTIVA S.A. market capitalisation for the company's overall valuation and market capitalisation.
ZENTIVA S.A. - Asset Composition Analysis
Current Asset Composition (September 2024)
ZENTIVA S.A.'s total assets of RON1.85 Billion consist of 82.6% current assets and 17.4% non-current assets. Review debt load of ZENTIVA S.A. to assess the company's total debt and financial obligations.
| Asset Category | Amount (RON) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RON0.00 | 1.9% |
| Accounts Receivable | RON550.66 Million | 31.8% |
| Inventory | RON192.97 Million | 11.1% |
| Property, Plant & Equipment | RON0.00 | 0.0% |
| Intangible Assets | RON16.22 Million | 0.9% |
| Goodwill | RON11.65 Million | 0.7% |
Asset Composition Trend (2019–2024)
This chart illustrates how ZENTIVA S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See SCD share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ZENTIVA S.A.'s current assets represent 82.6% of total assets in 2024, an increase from 79.4% in 2019.
- Cash Position: Cash and equivalents constituted 1.9% of total assets in 2024, down from 38.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 31.8% of total assets.
ZENTIVA S.A. Competitors by Total Assets
Key competitors of ZENTIVA S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥29.95 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
ASPEN PHAR.UN.ADR /1 O.N.
F:LDZU
|
Germany | €128.04 Billion |
ZENTIVA S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.85 | 4.06 | 4.72 |
| Quick Ratio | 4.30 | 3.46 | 3.90 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RON1.23 Billion | RON1.01 Billion | RON704.20 Million |
ZENTIVA S.A. - Advanced Valuation Insights
This section examines the relationship between ZENTIVA S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.10 |
| Latest Market Cap to Assets Ratio | 0.42 |
| Asset Growth Rate (YoY) | 15.6% |
| Total Assets | RON1.73 Billion |
| Market Capitalization | $723.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values ZENTIVA S.A.'s assets below their book value (0.42x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: ZENTIVA S.A.'s assets grew by 15.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for ZENTIVA S.A. (2019–2024)
The table below shows the annual total assets of ZENTIVA S.A. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-09-30 | RON1.73 Billion ≈ $398.09 Million |
+15.62% |
| 2023-09-30 | RON1.50 Billion ≈ $344.31 Million |
+24.42% |
| 2022-09-30 | RON1.21 Billion ≈ $276.73 Million |
+14.82% |
| 2021-09-30 | RON1.05 Billion ≈ $241.01 Million |
+1.58% |
| 2020-09-30 | RON1.03 Billion ≈ $237.25 Million |
+1.51% |
| 2019-09-30 | RON1.02 Billion ≈ $233.73 Million |
-- |
About ZENTIVA S.A.
Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. The company develops pharmaceutical products in various therapeutic areas, such as cardiovascular diseases, anti-inflammatory and pain-relieving medications, urologists, blood diseases, gastrointestinal and metabolic disorders, central nervous system, infections, respir… Read more